Specialty Drug, Specialty Pharmacy
JNJ’s Multiple Sclerosis Drug Ponvory Available From Covance Specialty Pharmacy
26
Mar
Mar
The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced that the FDA approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS). PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven […]
